Canaccord Genuity Downgrades Biogen (BIIB) to Hold

March 21, 2019 11:18 AM
Canaccord Genuity analyst Sumant Kulkarni downgraded Biogen (NASDAQ: BIIB) from to Hold with a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades

Next Articles